本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Y-mAbs Therapeutics, Inc.

4.69
+0.15003.30%
盘后4.690.00000.00%16:40 EDT
成交量:10.70万
成交额:49.63万
市值:2.12亿
市盈率:-7.00
高:4.73
开:4.52
低:4.51
收:4.54
数据加载中...

公司资料

公司名字:
Y-mAbs Therapeutics, Inc.
交易所:
NASDAQ
成立时间:
2015
员工人数:
104
公司地址:
202 Carnegie Center,Suite 301,Princeton,New Jersey,United States
邮编:
08540
传真:
- -
简介:
Y-mAbs Therapeutics, Inc.于2015年4月30日根据特拉华州法律注册成立。该公司是一家商业化阶段的生物制药公司,专注于新型放射免疫疗法和基于抗体的治疗产品的开发和商业化,用于治疗癌症。该公司正在利用专有的放射免疫疗法和抗体平台和专业知识来开发广泛的创新药物组合。

董事

名称
职位
Claus Juan Moller San Pedro
Chief Executive Officer and Director
Thomas Gad
Founder, Chairman of the Board of Director, President, Head of Business Development
Bo Kruse
Executive Vice President, Secretary, Treasurer, Chief Financial Officer and Director
Ashutosh Tyagi
Director
David N. Gill
Director
Gregory Raskin
Director
James I. Healy
Director
Johan Wedell Wedellsborg
Director
Michael Buschle
Director

股东

名称
职位
Claus Juan Moller San Pedro
Chief Executive Officer and Director
Joris Wiel Jan Wilms
Senior Vice President and Chief Operating Officer
Bo Kruse
Executive Vice President, Secretary, Treasurer, Chief Financial Officer and Director
Steen Lisby
Senior Vice President and Chief Medical Officer
Torben Lund Hansen
Senior Vice President and Head of Technical Operations
Thomas Gad
Founder, Chairman of the Board of Director, President, Head of Business Development